<DOC>
	<DOCNO>NCT02014506</DOCNO>
	<brief_summary>Purpose study : This phase I/II trial evaluate safety feasibility TCRαβ-depleted graft haploidentical family donor treat child adolescent malignant non-malignant disease .</brief_summary>
	<brief_title>Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation Children Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<criteria>A . Disease inclusions 1 . Hematologic malignancy : Acute lymphoblastic leukemia include induction failure , CR1 ( Ph+ , ( 4:11 ) , hypodiploid high risk feature ) , ≥ CR2 , infant ALL MLL unfavorable feature Acute myeloid leukemia exclude CR1 ( 8:21 ) , inv ( 16 ) , ( 15:17 ) , Down syndrome Myelodysplastic syndrome : RCC 7 RCC need transfusion Chronic myeloid leukemia AP Juvenile myelomonocytic leukemia Malignant lymphoma , NHL HD , fail autologous HSCT Other 2 . Nonhematologic malignancy Relapsed refractory solid tumor include neuroblastoma , rhabdomyosarcoma 3 . Nonmalignant hematologic disease Acquired severe severe aplastic anemia Fanconi anemia Paroxysmal nocturnal hemoglobinuria Congenital dyserythropoietic anemia Others 4 . Inherited metabolic disease Hemophagocytic lymphohistiocytosis Malignant osteopetrosis Storage diseases Others B . Recipient inclusion 1 . Age &lt; 21 year 2 . No HLAidentical stem cell donor available 3 . LanskyPlay performance score &gt; 60 4 . No active infection time transplantation 1 . HIVinfection 2 . Presence active serious infection 3 . Cardiac ejection fraction &lt; 35 % echocardiography 4 . Severe pulmonary dysfunction ( DLCO &lt; 30 % ) 5 . Liver function abnormality bilirubin &gt; 4mg/dL elevation transaminase &gt; 400U/L 6 . Concurrent severe uncontrolled medical disease 7 . Patients pregnant 8 . Patients unwilling unable comply protocol unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Children adolescent</keyword>
	<keyword>Malignant disease</keyword>
	<keyword>Non-malignant disease</keyword>
	<keyword>TCRαβ depletion</keyword>
	<keyword>Haploidentical hematopoietic stem cell transplantation</keyword>
</DOC>